Blab AI
AI Adoption in North Carolina Healthcare Highlights Opportunities and Challenges
On May 21, 2026, a national broadcast drew attention to a stark reality: the United States spends more on health care than any other high‑income country, yet its citizens enjoy a lower life expectancy and face significant barriers to care. The program framed the conversation around the rapid uptake of artificial intelligence (AI) in medicine, citing drug discovery, mental‑health chatbots, and streamlined administrative workflows as key examples.
Across the country, AI is already embedded in several clinical arenas. The show noted that machine‑learning models accelerate drug development, conversational agents support patients with mental‑health conditions, and automated tools free physicians from routine electronic health record tasks. A July 2024 LinkedIn article described a shift from “Ambient AI,” which merely records data, to “Agentic workflows,” which act on that data to navigate complex clinical and administrative tasks. A March 2024 Coasty blog highlighted that doctors spend more time clicking through electronic health records than touching patients, underscoring the urgency of automation.
North Carolina has taken a proactive stance. A 2025 article enumerated ten AI applications employed by state health‑care providers, including machine‑learning models that help pulmonologists detect lung cancer early. A 2026 WXXI report spotlighted research teams developing AI tools that integrate patient data—data that would otherwise remain siloed—to diagnose and treat residents more quickly. The state’s Department of Health and Human Services has also funded projects that draft patient messages from doctors.
The University of North Carolina at Charlotte’s Computational Intelligence to Predict Health and Environmental Risks (CIPHER) center, co‑directed by Dan Janies, has leveraged AI to monitor dangerous viruses. A 2025 Charlotte Optimist article reported that Janies’ team predicted the Omicron surge before it began. A 2026 Spectrum News piece announced that the CIPHER lab can now trace the source of the parasite Cyclospora, demonstrating its capacity to combine DNA sequencing with AI for public‑health investigations.
Experts interviewed for the program stressed the need for stronger safeguards. Janies warned that while AI can accelerate disease surveillance, it also raises privacy concerns when handling genomic data. Marschall Runge, a University of Michigan internal‑medicine professor, noted that the absence of clear regulatory standards makes it difficult for clinicians to adopt AI tools safely. Both agreed that patient consent and data‑protection protocols must be embedded in AI systems from the outset.
Patient attitudes toward AI remain ambivalent. An April 2026 poll by the Ohio State University Wexner Medical Center surveyed 1,007 adults, finding that only 42 % were open to AI being used as part of their health care. The same poll identified privacy and data‑security concerns as the primary reasons for reluctance.
In sum, AI is increasingly woven into North Carolina’s health‑care fabric, from early lung‑cancer detection to pathogen source tracing. Nationally, AI is expanding into drug development, mental‑health support, and administrative automation. Yet the pace of adoption is outstripping the creation of robust guardrails and regulatory frameworks, leaving privacy, data‑security, and patient acceptance as pressing, unresolved challenges.
Across the country, AI is already embedded in several clinical arenas. The show noted that machine‑learning models accelerate drug development, conversational agents support patients with mental‑health conditions, and automated tools free physicians from routine electronic health record tasks. A July 2024 LinkedIn article described a shift from “Ambient AI,” which merely records data, to “Agentic workflows,” which act on that data to navigate complex clinical and administrative tasks. A March 2024 Coasty blog highlighted that doctors spend more time clicking through electronic health records than touching patients, underscoring the urgency of automation.
North Carolina has taken a proactive stance. A 2025 article enumerated ten AI applications employed by state health‑care providers, including machine‑learning models that help pulmonologists detect lung cancer early. A 2026 WXXI report spotlighted research teams developing AI tools that integrate patient data—data that would otherwise remain siloed—to diagnose and treat residents more quickly. The state’s Department of Health and Human Services has also funded projects that draft patient messages from doctors.
The University of North Carolina at Charlotte’s Computational Intelligence to Predict Health and Environmental Risks (CIPHER) center, co‑directed by Dan Janies, has leveraged AI to monitor dangerous viruses. A 2025 Charlotte Optimist article reported that Janies’ team predicted the Omicron surge before it began. A 2026 Spectrum News piece announced that the CIPHER lab can now trace the source of the parasite Cyclospora, demonstrating its capacity to combine DNA sequencing with AI for public‑health investigations.
Experts interviewed for the program stressed the need for stronger safeguards. Janies warned that while AI can accelerate disease surveillance, it also raises privacy concerns when handling genomic data. Marschall Runge, a University of Michigan internal‑medicine professor, noted that the absence of clear regulatory standards makes it difficult for clinicians to adopt AI tools safely. Both agreed that patient consent and data‑protection protocols must be embedded in AI systems from the outset.
Patient attitudes toward AI remain ambivalent. An April 2026 poll by the Ohio State University Wexner Medical Center surveyed 1,007 adults, finding that only 42 % were open to AI being used as part of their health care. The same poll identified privacy and data‑security concerns as the primary reasons for reluctance.
In sum, AI is increasingly woven into North Carolina’s health‑care fabric, from early lung‑cancer detection to pathogen source tracing. Nationally, AI is expanding into drug development, mental‑health support, and administrative automation. Yet the pace of adoption is outstripping the creation of robust guardrails and regulatory frameworks, leaving privacy, data‑security, and patient acceptance as pressing, unresolved challenges.
